{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:39:28Z","timestamp":1794487168846,"version":"4.9.1"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.282220","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T07:15:23Z","timestamp":1683789323000},"page":"2830-2836","source":"Crossref","is-referenced-by-count":14,"title":["KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma"],"prefix":"10.3324","volume":"108","author":[{"given":"Amandine","family":"Decroos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Cheminant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Carras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Parinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Giustiniani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lhermitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"De Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Bonnafous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Genestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"52978","doi-asserted-by":"crossref","unstructured":"Bagot M, Porcu P, Marie-Cardine A. IPH4102, a first-inclass anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. Lancet Oncol. 2019; 20(8):1160-1170.","DOI":"10.1016\/S1470-2045(19)30320-1"},{"key":"52979","doi-asserted-by":"crossref","unstructured":"Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005; 5(3):201-214.","DOI":"10.1038\/nri1570"},{"key":"52980","doi-asserted-by":"crossref","unstructured":"Ortonne N, Huet D, Gaudez C. Significance of circulating T-cell clones in Sezary syndrome. Blood. 2006; 107(10):4030-4038.","DOI":"10.1182\/blood-2005-10-4239"},{"key":"52981","doi-asserted-by":"crossref","unstructured":"Battistella M, Leboeuf C, Ram-Wolff C. KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting. Blood. 2017; 130(26):2900-2902.","DOI":"10.1182\/blood-2017-06-792382"},{"key":"52982","doi-asserted-by":"crossref","unstructured":"Cheminant M, Lhermitte L, Bruneau J. KIR3DL2 contributes to the typing of acute-type adult T-cell leukemia and is a potential therapeutic target. Blood. 2022; 140(13):1522-1532.","DOI":"10.1182\/blood.2022016765"},{"key":"52983","doi-asserted-by":"crossref","unstructured":"Thonnart N, Caudron A, Legaz I. KIR3DL2 is a coinhibitory receptor on S\u00e9zary syndrome malignant T cells that promotes resistance to activation-induced cell death. Blood. 2014; 124(22):3330-3332.","DOI":"10.1182\/blood-2014-09-598995"},{"key":"52984","doi-asserted-by":"crossref","unstructured":"Ghazi B, Thonnart N, Bagot M, Bensussan A, Marie-Cardine A. KIR3DL2\/CpG ODN interaction mediates S\u00e9zary syndrome malignant T cell apoptosis. J Invest Dermatol. 2015; 135(1):229-237.","DOI":"10.1038\/jid.2014.286"},{"key":"52985","doi-asserted-by":"crossref","unstructured":"Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP\/DAP12 in CD4+ T cells. J Exp Med. 2003; 197(4):437-449.","DOI":"10.1084\/jem.20020383"},{"key":"52986","doi-asserted-by":"crossref","unstructured":"Marie-Cardine A, Huet D, Ortonne N. Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome. Blood. 2007; 109(11):5064-5065.","DOI":"10.1182\/blood-2007-02-071993"},{"key":"52987","doi-asserted-by":"crossref","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015; 15(8):486-499.","DOI":"10.1038\/nri3862"},{"key":"52988","doi-asserted-by":"crossref","unstructured":"Carras S, Chartoire D, Mareschal S. Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigentic reprogramming. J Clin Invest. 2021; 131(13):e139675.","DOI":"10.1172\/JCI139675"},{"key":"52989","doi-asserted-by":"crossref","unstructured":"Li G, Yu M, Weyand CM, Goronzy JJ. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood. 2009; 114(16):3422-3430.","DOI":"10.1182\/blood-2009-01-200170"},{"key":"52990","doi-asserted-by":"crossref","unstructured":"Chan H-W, Kurago ZB, Stewart CA. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med. 2003; 197(2):245-255.","DOI":"10.1084\/jem.20021127"},{"key":"52991","doi-asserted-by":"crossref","unstructured":"Santourlidis S, Graffmann N, Christ J, Uhrberg M. Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J Immunol. 2008; 180(1):418-425.","DOI":"10.4049\/jimmunol.180.1.418"},{"key":"52992","doi-asserted-by":"crossref","unstructured":"Gravett AM, Dalgleish AG, Copier J. In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells. Sci Rep. 2019; 9(1):1544.","DOI":"10.1038\/s41598-018-38190-2"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282220\/76127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282220\/76128","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11076\/75614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:04Z","timestamp":1794045844000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282220","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}